GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » EDX Medical Group PLC (AQSE:EDX) » Definitions » Additional Paid-In Capital

EDX Medical Group (AQSE:EDX) Additional Paid-In Capital : £0.00 Mil(As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is EDX Medical Group Additional Paid-In Capital?



EDX Medical Group Additional Paid-In Capital Historical Data

The historical data trend for EDX Medical Group's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EDX Medical Group Additional Paid-In Capital Chart

EDX Medical Group Annual Data
Trend
Additional Paid-In Capital

EDX Medical Group Semi-Annual Data
Additional Paid-In Capital

EDX Medical Group Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

EDX Medical Group Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of EDX Medical Group's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


EDX Medical Group Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
210-211 Milton Road, Cambridge, GBR, CB4 0WA
EDX Medical Group Plc develops and validates digitally enabled diagnostic products and services to help predict disease risk, inform clinical decision-making and accelerate the development of new medicines in the areas of cancer, heart disease, neurology and infectious diseases.

EDX Medical Group Headlines

No Headlines